Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir

Journal of Medical Virology

Volumn 64, Issue 2, 2001, Pages 195-198

  Diaz, Belkis I ^a,c   Sariol, Carlos A ^a   Normann, Andrea ^a   Rodrguez, Licel ^b   Flehmig, Bertram ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Human papillomavirus; Neoplasia; Precancerous lesion; Topical treatment; Vulvar intraepithelial

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; DEOXYCYTIDINE PHOSPHATE; INTERFERON; ISOTRETINOIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CONDYLOMA; CONSERVATIVE TREATMENT; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; ILLNESS BEHAVIOR; SKIN ULCER; TERATOGENICITY; TREATMENT INDICATION; TREATMENT OUTCOME; VULVA TUMOR; VULVAR INTRAEPITHELIAL NEOPLASIA;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOSINE; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERONS; ISOTRETINOIN; NEOPLASM RECURRENCE, LOCAL; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; VULVAR NEOPLASMS;

HUMAN PAPILLOMAVIRUS; POMACANTHUS MACULOSUS;

EID: 0035038498     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.1036     Document Type: Article

References (22)

1. Preinvasive disease of the vulva and vagina
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
3. Treatment of vaginal dysplasia and carcinoma in situ with topical 5-fluorouracil
4. Therapeutic potential of HPMPC as an antiviral drug
5. Therapeutic potential of cidofovir (HPMPC, Vistide™) for the treatment of DNA virus (i.e., herpes-, papova-, pox- and adenovirus) infections
6. Human fibroblast interferon in cervical and vulvar epithelial neoplasia associated with papilloma viral infection
7. Human fibroblast interferon in cervical and vulvar epithelial neoplasia associated with viral cytopathic effects. A pilot study
8. Human papillomavirus infection and therapy with interferon
9. Efficiency of interferons on bowenoid papulosis and other precancerous lesion
10. Therapy of human papillomavirus infection and associated epithelial tumors
11. Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesion of the vulva and vagina
12. Risk factors for recurrent VIN. Role of multifocality and grade of disease
13. Cidofovir
14. Vulvar intraepithelial neoplasia
15. A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes
16. Successful treatment of progressive mucocutaneous infection due to acyclovir and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC)
17. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue
18. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs
19. Benign and preinvasive lesions of vulva and vagina
20. 2 laser
21. Failure of isotretinoin and interferon combination therapy for HPV-linked severe vulvar dysplasia
22. Topical and intralesional cidofovir: A review of pharmacology and therapeutic effects